Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Acton, Massachusetts. March 28, 2022 – Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”) a late-stage, pre-revenue diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced that Edwin “Ed” E. Rule, has joined the Company as Vice President Regulatory, Quality and Compliance. He will report to Neil Dey, Chief Executive Officer.

More details.


Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/lmbric5/public_html/ on line 5221